Tonner, H.; Hunn, S.; Auler, N.; Schmelter, C.; Pfeiffer, N.; Grus, F.H.
Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma. Int. J. Mol. Sci. 2022, 23, 13618.
https://doi.org/10.3390/ijms232113618
AMA Style
Tonner H, Hunn S, Auler N, Schmelter C, Pfeiffer N, Grus FH.
Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma. International Journal of Molecular Sciences. 2022; 23(21):13618.
https://doi.org/10.3390/ijms232113618
Chicago/Turabian Style
Tonner, Henrik, Selina Hunn, Nadine Auler, Carsten Schmelter, Norbert Pfeiffer, and Franz H. Grus.
2022. "Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma" International Journal of Molecular Sciences 23, no. 21: 13618.
https://doi.org/10.3390/ijms232113618
APA Style
Tonner, H., Hunn, S., Auler, N., Schmelter, C., Pfeiffer, N., & Grus, F. H.
(2022). Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma. International Journal of Molecular Sciences, 23(21), 13618.
https://doi.org/10.3390/ijms232113618